𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Developmental expression of p-glycoprotein (multidrug resistance gene product) in the rat brain

✍ Scribed by Matsuoka, Yasuji ;Okazaki, Mitsuhiro ;Kitamura, Yoshihisa ;Taniguchi, Takashi


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
430 KB
Volume
39
Category
Article
ISSN
0022-3034

No coin nor oath required. For personal study only.

✦ Synopsis


P-Glycoprotein (PGP), a product of the multidrug resistance gene (mdr), acts as an adenosine triphosphate-dependent drug efflux system in cells. Initially, PGP was found in cancer cells, but it is now known that PGP is richly distributed in the adult brain. Passage to the central nervous system is limited by the blood-brain barrier (BBB), and mdr1 gene-deficient mice showed up-regulation of BBB permeability. In this study, we examined the expression and localization of PGP in the rat brain during development. PGP protein was predominantly detected in the membrane fraction of the adult rat brain, although it was also faintly detected in the cytosolic fraction. PGP protein in the membrane fraction was undetectable in the embryo and early stages of postnatal development by immunoblotting studies, was first detected on postnatal day (P) 7, and then gradually increased to reach a plateau. Such changes were observed commonly in the cerebral cortex, hippocampus, and cerebellum. Immunohistochemical studies showed that PGP immunoreactivity was first detected on P7, and intense PGP immunoreactivity was observed in the adult rat brain. Double-immunolabeling studies revealed that PGP was colocalized with von Willebrand factor-immunoreactive capillaries. We further examined the colocalization of PGP and astrocytes using glial fibrillary acidic protein (GFAP) as a marker. Three-dimensional analysis showed that the GFAP-immunoreactive astrocytes possessed fine processes which ensheathed capillaries, but the PGP immunoreactivity did not colocalize with the GFAP immunoreactivity. These results indicate that PGP expression increased with postnatal development and is localized in the brain capillaries.


πŸ“œ SIMILAR VOLUMES


Differential expression of multidrug res
✍ Vibhor Jain; Satya N. Das; Kalpana Luthra; Nootan K. Shukla; Ranju Ralhan πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 164 KB πŸ‘ 2 views

Multidrug resistance (MDR) in human cancer is often associated with over-expression of the mdr-1 gene, which encodes a 170-kDa transmembrane protein, termed P-glycoprotein (P-gp). We evaluated the immunoreactivity of P-gp in oral tissues at different stages of tumorigenesis in the Indian population

Expression of the MDR1 gene product P-gl
✍ Catharina R.Β M. Dhooge; Barbara M.Β J. De Moerloose; Yves C.Β M. Benoit; Nadine Va πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 148 KB πŸ‘ 1 views

expression of the multidrug resistance gene (MDR1) product P-gp in neuroblastoma (NB) is still a matter of debate. In this study, the role of the expression

Functional expression of p-glycoprotein
✍ X. DeclΓ¨ves; A. Regina; J.-L. Laplanche; F. Roux; B. Boval; J.-M. Launay; J.-M. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 164 KB πŸ‘ 1 views

Although it has been well established that the drug efflux pump P-glycoprotein (P-gp) protects the brain against the entry of cytotoxic drugs, its real in situ localization, i.e., at brain capillary endothelial cells or on astrocyte foot processes, is still controversial. The aim of this study was t

Combined therapy of multidrug-resistant
✍ Yasuhiko Nishioka; Seiji Yano; Fujio Fujiki; Naofumi Mukaida; Kouji Matsushima; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 148 KB πŸ‘ 1 views

We determined whether transduction of the monocyte chemoattractant protein-1 (MCP-1) gene into MDR human lung cancer cells affected their tumorigenicity and sensitivity to antibody-dependent cellular cytotoxicity (ADCC) reaction mediated by the anti-P-glycoprotein (P-gp) monoclonal antibody MRK16. T